Safety Alerts & Recalls
What does this mean?
Today's alert is a follow-up to other recent communications from the FDA on this issue. Most physicians will have already taken into account the increased risk of infection when balancing risks versus benefits of using this product. Most physicians screen for tuberculosis prior to starting ENBREL therapy.
That said, if you are taking ENBREL it is important to tell your doctor if you have previously suffered from tuberculosis or develop symptoms of a more serious infection - such as unplanned weight loss, night sweats, fever or productive cough that don't seem to get better.
New black box warning
Amgen and Wyeth Pharmaceuticals today notified healthcare professionals about changes to the prescribing information for ENBREL. These changes include a new black box warning relating to an increased risk of serious infections, and the importance of screening for tuberculosis in patients treated with ENBREL.
For more information, please visit: more information here